Business Wire

KDDI Expands Relationship with Cleversafe, Selects Web-Scale Storage Leader to Support New KDDI Cloud Platform Service with Object Storage Offering for Enterprises

31.8.2015 13:05 | Business Wire

Del

Cleversafe, Inc., the web-scale storage market share leader, today announced that KDDI Corporate has selected Cleversafe’s web-scale data storage platform for its new object storage service within the KDDI Cloud Platform Service (KCPS). The service provides enterprises with a highly scalable and reliable cloud storage solution designed to address explosive data demands generated by the rapid growth of unstructured data.

As today’s enterprises struggle to manage and store the data deluge created by user-, application- and machine-generated information, interest in scalable public and private cloud storage solutions has skyrocketed. Addressing this demand, KDDI’s object storage service for enterprises offers highly scalable data storage with enterprise-class reliability, availability and security at public cloud economics. The new offering within KCPS leverages Cleversafe’s web-scale software platform that delivers petabyte-and-beyond scalability, with 15 nines of reliability and 15 times greater efficiency than traditional approaches.

Using a patented data dispersal technology, Cleversafe’s dsNet® storage system divides, encrypts and disperses information across multiple data center locations, significantly increasing data availability and security. With Cleversafe’s approach, the service stores information across KDDI’s three Japanese data centers, ensuring high levels of data security, continuous uptime and uninterrupted system performance, even in the event of a natural disaster or technical failure.

Providing an object storage service within KCPS builds on the success the company has experienced with its consumer cloud offering, Au Smart Pass, which today provides highly reliable and secure storage to 13 million KDDI customers. Cleversafe provides the scalable storage backbone for Au Smart Pass as well, ensuring continuous data availability and uninterrupted performance in the event of a hardware or software failure.

“We’re pleased to expand our relationship with Cleversafe, which is not only providing the technology underlying Au Smart Pass, but is now serving as our technology partner for KDDI Cloud Platform Service,” said Akihito Fujii, KDDI’s general manager of Cloud Service Development. “Leveraging Cleversafe’s technology, KCPS is able to deliver a solution that helps Japanese enterprises address their growing data storage needs with extreme scale and efficiency and without sacrificing performance, security or cost.”

“Cleversafe is a leader in object storage¹, a position that reflects its ability to deliver massive at-scale deployments with extreme efficiency and carrier-grade security and a strategy to continue leading the market as it grows,” said Ashish Nadkarni, IDC Research Director. “Their proven web-scale software platform gives customers like KDDI the storage solution they need to succeed in their own cloud storage services.”

“The new object storage service within the KDDI Cloud Platform Service provides a highly reliable and efficient storage solution to help enterprises tackle their growing data storage challenges,” said John Morris, president and CEO of Cleversafe. “KDDI is one of the most innovative companies in Japan, and we are very pleased to be at the core of its object storage offering, delivering the secure, web-scale data storage solution enterprises can trust.”

About Cleversafe, Inc.

Cleversafe, the web-scale storage market share leader, delivers a breakthrough private cloud software platform that solves petabyte-and-beyond storage challenges. Relied upon by the world’s largest data repositories, Cleversafe reduces 80 percent or more of storage costs while providing carrier-grade security, 15 nines of reliability and simplified storage management. For more information, please visit www.cleversafe.com.

¹ Nadkarni, A. (2014). IDC MarketScape: Worldwide Object-Based Storage 2014 Vendor Assessment

Contact information

Media contact:
Edelman for Cleversafe, Inc.
Erin Pace, (312) 297-6900
erin.pace@edelman.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom